NEW YORK and MELBOURNE, Australia, Dec. 21, 2017 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that the United States Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for its novel mesenchymal precursor cell (MPC) therapy in the treatment of heart failure patients with left ventricular […]
Author: Ken Dropiewski
Mentice Acquires Endovascular Business from Medical Simulation Corporation
GOTHENBURG, Sweden–(BUSINESS WIRE)–Mentice boosts its US development presence and adds a clinical training service line with the acquisition of Medical Simulation Corporation’s (MSC) Medical Products division. Mentice is the global leader of simulation-based performance solutions for endovascular therapies. Under the agreement, Mentice will acquire the assets of the MSC’s Medical […]
Impulse Dynamics’ Optimizer® Receives CFDA Approval in China
ORANGEBURG, New York and STUTTGART, Germany, December 18, 2017 /PRNewswire/ — The China Food and Drug Administration (CFDA) has approved Impulse Dynamics’ Optimizer® system for treatment of chronic heart failure. The announcement was made on December 12, 2017 by Impulse Dynamics’ CEO, Dr. Simos Kedikoglou. “This is a major milestone for Impulse Dynamics, as it will help us […]
Avinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy Device
REDWOOD CITY, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced Conformité Européenne (CE) Marking approval for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of PAD. The novel […]
For Heart Disease Patients, Better Outcomes are Tied to Tying the Knot
by Ken Dropiewski, Prime-Core Executive Search (ken@prime-core.com) Marriage is the age old punch line to bad jokes about dying early, before your time. But new studies indicate that, for some, marriage actually extends life and improves outcomes! The study, by Arshed Quyyumi, of Emory University in Atlanta reports that heart disease […]
XableCath Scores FDA Clearance for Broadly Effective Catheter
SALT LAKE CITY–(BUSINESS WIRE)– XableCath, a clinical stage medical device company, announced its XableCath blunt tip support catheter has received clearance from the FDA. The blunt tip catheter facilitates true lumen passage of lesions, both above and below the knee, in the peripheral vasculature. Procedures using the XableCath blunt tip catheters can […]
Avinger Secures Waiver and Consent to CRG Loan Agreement
REDWOOD CITY, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) — Avinger, Inc. (NASDAQ:AVGR), a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the Lumivascular approach to treating vascular disease, announced today it has entered into an agreement with CRG to waive […]
Abbott Raising Quarterly Dividend for 46th Straight Year
ABBOTT PARK, Ill., Dec. 15, 2017 /PRNewswire/ — The board of directors of Abbott (NYSE: ABT) today increased the company’s quarterly common dividend to 28 cents per share from 26.5 cents per share. This marks the 376th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Feb. 15, 2018, to shareholders of record at […]
Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc.(NYSE American: CVRS), a leading developer of precision vascular robotics, announced today the first commercial installation of a CorPath GRX System outside of the United States. The system was purchased by the Apex Heart Institute in Ahmedabad, India, a state of the art cardiology center. […]
Centers Commence Enrollment in KNOCOUT PE Study to Measure the Impact of Shorter, Even Safer EKOS® Therapy Protocols for Pulmonary Embolism
BOTHELL, Wash.–(BUSINESS WIRE)–BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the commencement of the KNOCOUT PE study. The KNOCOUT PE study will measure how hospitals and patients are benefitting from a new standard of care in the treatment of Pulmonary Embolism utilizing EKOS® therapy with faster, and even […]
Recent
UBC MOSAIC and LifeLabs Unlock New Ways to Manage and Predict Heart Health
Ruixiang Silicone Releases Platinum-Cured Medical Silicone Tubing for Cardiac, Infusion, and Hemodialysis Device Manufacturers
AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions
Popular
- No commented posts yet